Skip to main content

Table 3 Relation between clinicopathological parameter and SBF2-AS1 expression of BC patients

From: Down-regulated lncRNA SBF2-AS1 inhibits tumorigenesis and progression of breast cancer by sponging microRNA-143 and repressing RRS1

Clinicopathological parameter

 

SBF2-AS1

P value

High expression (n = 39)

Low expression (n = 11)

Age (years)

 < 50

29

24

5

0.491

 ≥ 50

21

15

6

Histological type

 Ductal

45

36

9

0.167

 Lobular

2

1

2

 Other

3

2

1

Histological grade

 I

14

10

4

0.142

 II

26

23

3

 III

10

6

4

Lymph node metastasis

 YES

20

12

8

0.012

 NO

30

27

3

TNM stage

 I

4

3

1

0.977

 II

36

28

8

 III

10

8

2

Tumor size

 < 2 cm

19

10

9

0.001

 ≥ 2 cm

31

29

2

Clinical stage

 I

5

1

4

0.004

 II

28

24

4

 III

17

14

3

Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us